ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

QP. Quantum Phar.

84.2374
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Quantum Phar. LSE:QP. London Ordinary Share GB00BRTL8Q42 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 84.2374 84.00 84.75 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Quantum Phar. Share Discussion Threads

Showing 1101 to 1116 of 1550 messages
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older
DateSubjectAuthorDiscuss
05/8/2016
07:20
Yes and good to think that some products are available for these poor people.
hazl
05/8/2016
07:12
from todays RNS:

"Whilst it is relatively early following the launch of the range, and as such we are still in the market access phase, the initial response from clinical teams at hospitals has been encouraging, and the use in their units has provided favourable patient feedback. We are positive on the outlook for the range over the short to medium term."

cougar99
03/8/2016
06:16
and a nice upward thrust in share price yesterday .... QP making progress in a slow but sure way .... keep making the medicine and look forward to the future ....
cougar99
01/8/2016
11:22
Good to see Oryx International Growth Fund buying and going above 3% with 3.78m shares:
rivaldo
27/7/2016
09:27
I don't think they are a bad little firm and they have regular demand.

IMO

hazl
26/7/2016
21:33
absolutely dacian

just to qualify I don't have great quantities in anything at present.

hazl
26/7/2016
15:38
N+1 Singer's forecasts are currently:

this year : 6.5p EPS, 1.8p dividend
next year : 7.6p EPS, 2.3p dividend

I got hold of their note from May, which concluded:

"Shares remain undervalued

The shares continue to look heavily oversold, standing on a Jan-17 P/E of just
9.4x. We see the current valuation as being underpinned by the Specials business, with the Niche Pharmaceuticals and Medication Adherence activities effectively in for nothing. We see an intrinsic valuation range of 97-132p based on a peer group analysis and a DCF."

rivaldo
26/7/2016
12:01
YES I believe its just having a breather after a rise.
Trend LOOKS UP from where I am standing....higher lows....and so on

IMO

hazl
26/7/2016
08:59
But consistently failed to meet targets.
r ball
26/7/2016
08:39
Drifting. Needs CEO in place and renewed confidence. Cannot see many lining up to take the job.
r ball
26/7/2016
08:05
Far too much information for me on this occasion in the RNS
davr0s
26/7/2016
08:00
Perhaps the share price will bottom out?
busterdog2
26/7/2016
07:43
Blimey, I see QP.'s latest product relates to addressing a very unpleasant condition.
shanklin
21/7/2016
19:42
Couple chunky buys but made no difference to price (yet)
davr0s
21/7/2016
08:00
Front page headlines in the Times today too. Free advertising!
busterdog2
21/7/2016
04:27
Just what the Doctor ordered, albeit in small doses:

Vitamin D supplements 'advised for everyone'

cougar99
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older

Your Recent History

Delayed Upgrade Clock